PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Partners with Asterion Cannabis to Develop Organic Cannabinoid Products
PreveCeutical Medical Inc. enters into a joint venture agreement with Asterion Cannabis Inc. to develop several nature-based cannabinoid products; the products will help the company respond to the demands for personalized and effective cannabis therapies The development agreement will see Asterion inject funds at cost, while PreveCeutical will contribute by way of opening its research resources, including personnel for use in the project The percentage ownership of intellectual and product rights from the agreement will be shared between Asterion and PreveCeutical in the ratio of 80 percent to 20 percent Since the agreement involves related parties including current and former…